Suppr超能文献

出院诊断为子宫内膜异位症后的癌症风险。

Cancer risk after a hospital discharge diagnosis of endometriosis.

作者信息

Brinton L A, Gridley G, Persson I, Baron J, Bergqvist A

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

Am J Obstet Gynecol. 1997 Mar;176(3):572-9. doi: 10.1016/s0002-9378(97)70550-7.

Abstract

OBJECTIVES

Our goal was to determine the risk of cancer after hospitalization for endometriosis.

STUDY DESIGN

Records of 20,686 women hospitalized with endometriosis during the period 1969 to 1983, as identified through the nationwide Swedish Inpatient Register, were linked against the National Swedish Cancer Registry through 1989 to identify all subsequent diagnoses of cancer. The study subjects were followed up for a mean of 11.4 years, with the cohort contributing 216,851 woman years of follow-up. Standardized incidence ratios were computed by the use of age- and period-specific incidence rates derived from the Swedish population. Because of the high proportion of subjects with gynecologic operations (55.6%), evaluation of the risk of gynecologic cancers involved truncation of person years at the time of any such operation.

RESULTS

The overall cancer risk was 1.2 (95% confidence interval 1.1 to 1.3). Significant excesses were observed for breast cancer (standardized incidence ratio = 1.3, 95% confidence interval 1.1 to 1.4), ovarian cancer (1.9, 1.3 to 2.8), and hematopoietic malignancies (1.4, 1.0 to 1.8); this latter excess was largely driven by an excess risk of non-Hodgkin's lymphoma (1.8, 1.2 to 2.6). The risk of ovarian cancer was particularly elevated among subjects with a long-standing history of ovarian endometriosis (4.2, 2.0 to 7.7). Cervical cancer risk was slightly reduced (0.7, 0.4 to 1.3) whereas no association was observed for cancer of the endometrium (1.1, 0.6 to 1.9).

CONCLUSIONS

These findings suggest that further attention be given to the risk of breast, ovarian and hematopoietic cancers among women with endometriosis and to exploring possible hormonal and immunologic reasons for the excess risks.

摘要

目的

我们的目标是确定子宫内膜异位症住院治疗后患癌风险。

研究设计

通过瑞典全国住院患者登记系统识别出的1969年至1983年期间因子宫内膜异位症住院的20686名女性的记录,与瑞典国家癌症登记系统进行关联,直至1989年,以确定所有后续癌症诊断情况。研究对象平均随访11.4年,该队列贡献了216851人年的随访数据。使用源自瑞典人群的年龄和时期特异性发病率计算标准化发病率比。由于接受妇科手术的受试者比例较高(55.6%),对妇科癌症风险的评估涉及在任何此类手术时截断人年数。

结果

总体患癌风险为1.2(95%置信区间1.1至1.3)。乳腺癌(标准化发病率比 = 1.3,95%置信区间1.1至1.4)、卵巢癌(1.9,1.3至2.8)和造血系统恶性肿瘤(1.4,1.0至1.8)的风险显著增加;后者的增加主要由非霍奇金淋巴瘤的风险增加(1.8,1.2至2.6)驱动。在有长期卵巢子宫内膜异位症病史的受试者中,卵巢癌风险尤其升高(4.2,2.0至7.7)。宫颈癌风险略有降低(0.7,0.4至1.3),而子宫内膜癌未观察到关联(1.1,0.6至1.9)。

结论

这些发现表明,应进一步关注子宫内膜异位症女性患乳腺癌、卵巢癌和造血系统癌症的风险,并探索风险增加的可能激素和免疫原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验